What it sells
Targeting the Tumor Ecosystem to address cancer drug resistance.
Business model breakdown
Economics: what it saves and how it charges
UnverifiedPreclinical drug discovery company; no product revenue shown.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2022 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.